Thu, May 5, 2022
Wed, May 4, 2022
Tue, May 3, 2022
Mon, May 2, 2022

Josh Schimmer Downgraded (SPRO) to Hold and Decreased Target to $2 on, May 4th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. d-and-decreased-target-to-2-on-may-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Josh Schimmer of Evercore ISI Group, Downgraded "Spero Therapeutics, Inc." (SPRO) to Hold and Decreased Target from $40 to $2 on, May 4th, 2022.

Josh has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Josh's Rating of Hold.



This is the rating of the analyst that currently disagrees with Josh


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Monday, April 18th, 2022

Publication Contributing Sources